RYAHX
Price
$139.53
Change
+$0.96 (+0.69%)
Updated
Dec 4 closing price
Net Assets
12.63M
UOPSX
Price
$101.06
Change
-$0.21 (-0.21%)
Updated
Dec 4 closing price
Net Assets
1.74B
Interact to see
Advertisement

RYAHX vs UOPSX

Header iconRYAHX vs UOPSX Comparison
Open Charts RYAHX vs UOPSXBanner chart's image
Rydex Mid-Cap 1.5x Strategy A
Price$139.53
Change+$0.96 (+0.69%)
VolumeN/A
Net Assets12.63M
ProFunds UltraNASDAQ-100 Svc
Price$101.06
Change-$0.21 (-0.21%)
VolumeN/A
Net Assets1.74B
RYAHX vs UOPSX Comparison Chart in %
View a ticker or compare two or three
VS
RYAHX vs. UOPSX commentary
Dec 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYAHX is a Buy and UOPSX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
UOPSX has more cash in the bank: 1.74B vs. RYAHX (12.6M). RYAHX pays higher dividends than UOPSX: RYAHX (0.69) vs UOPSX (0.00). RYAHX was incepted earlier than UOPSX: RYAHX (22 years) vs UOPSX (28 years). UOPSX (2.53) is less costly to investors than RYAHX (1.79). RYAHX is a more actively managed with annual turnover of: 94.00 vs. UOPSX (22.00). RYAHX has a lower initial minimum investment than UOPSX: RYAHX (2500) vs UOPSX (15000). UOPSX annual gain was more profitable for investors over the last year : 21.64 vs. RYAHX (-5.11). UOPSX return over 5 years is better than : 60.62 vs. RYAHX (33.20).
RYAHXUOPSXRYAHX / UOPSX
Total Expense Ratio1.672.5366%
Annual Report Gross Expense Ratio1.792.5371%
Fund Existence22 years28 years-
Gain YTD6.09028.23222%
Front Load5%N/A-
Min. Initial Investment25001500017%
Min. Initial Investment IRAN/AN/A-
Net Assets12.6M1.74B1%
Annual Yield % from dividends0.690.00-
Returns for 1 year-5.1121.64-24%
Returns for 3 years38.90204.4919%
Returns for 5 years33.2060.6255%
Returns for 10 years133.16585.7023%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CMPX5.540.26
+4.92%
Compass Therapeutics
PAY36.501.66
+4.76%
Paymentus Holdings
EW85.781.80
+2.14%
Edwards Lifesciences Corp
BGI1.090.01
+1.05%
Birks Group
CXDO6.71-0.04
-0.59%
Crexendo